MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hanas, J. S.
Right arrow Articles by Cheng, Y.-G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanas, J. S.
Right arrow Articles by Cheng, Y.-G.

Vol. 56, Issue 5, 982-988, November 1999

Lead Inhibition of DNA-Binding Mechanism of Cys2His2 Zinc Finger Proteins

Jay S. Hanas, Justin S. Rodgers, John A. Bantle,1 and Yong-Gang Cheng

Department of Biochemistry and Molecular Biology, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma

The association of lead with chromatin in cells suggests that deleterious metal effects may in part be mediated through alterations in gene function. To elucidate if and how lead may alter DNA binding of cysteine-rich zinc finger proteins, lead ions were analyzed for their ability to alter the DNA binding mechanism of the Cys2His2 zinc finger protein transcription factor IIIA (TFIIIA). As assayed by DNase I protection, the interaction of TFIIIA with the 50-bp internal control region of the 5S ribosomal gene was partially inhibited by 5 µM lead ions and completely inhibited by 10 to 20 µM lead ions. Preincubation of free TFIIIA with lead resulted in DNA-binding inhibition, whereas preincubation of a TFIIIA/5S RNA complex with lead did not result in DNA-binding inhibition. Because 5S RNA binds TFIIIA zinc fingers, this result is consistent with an inhibition mechanism via lead binding to zinc fingers. The complete loss of DNase I protection on the 5S gene indicates the mechanism of inhibition minimally involves the N-terminal fingers of TFIIIA. Inhibition was not readily reversible and occurred in the presence of an excess of beta -mercaptoethanol. Inhibition kinetics were fast, progressing to completion in ~5 min. Millimolar concentrations of sulfhydryl-specific arsenic ions were not inhibitory for TFIIIA binding. Micromolar concentrations of lead inhibited DNA binding by Sp1, another Cys2His2 finger protein, but not by the nonfinger protein AP2. Inhibition of Cys2His2 zinc finger transcription factors by lead ions at concentrations near those known to have deleterious physiological effects points to new molecular mechanisms for lead toxicity in promoting disease.


Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Biol. Reprod.Home page
C. Taupeau, J. Poupon, D. Treton, A. Brosse, Y. Richard, and V. Machelon
Lead Reduces Messenger RNA and Protein Levels of Cytochrome P450 Aromatase and Estrogen Receptor {beta} in Human Ovarian Granulosa Cells
Biol Reprod, June 1, 2003; 68(6): 1982 - 1988.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
T. I. Lidsky and J. S. Schneider
Lead neurotoxicity in children: basic mechanisms and clinical correlates
Brain, January 1, 2003; 126(1): 5 - 19.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
P. Li and T. G. Rossman
Genes Upregulated in Lead-Resistant Glioma Cells Reveal Possible Targets for Lead-Induced Developmental Neurotoxicity
Toxicol. Sci., November 1, 2001; 64(1): 90 - 99.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics